http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107083442-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2017-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107083442-B |
| titleOfInvention | BRCA1/2 gene variation combined detection kit and application thereof |
| abstract | The invention provides a BRCA1/2 gene variation combined detection kit, and belongs to the field of gene variation detection. The kit comprises the following reagents: BRCA1 gene primer group, BRCA2 gene primer group, polymerase, PCR reaction liquid, digestive enzyme, ligase buffer, adapter, fluorescent probe, Taq enzyme for qPCR reaction, qPCR primer and qPCR reaction liquid. The combined detection kit provided by the invention can simultaneously detect mutation sites of BRCA1/2 genes of breast cancer, so that the sensitivity of an experimental result is high, the mutation rate of less than 5% can be detected, the detection sensitivity is greatly improved, the problems in the prior art are overcome, and meanwhile, the whole experimental process meets the requirement of large-batch and rapid detection. |
| priorityDate | 2017-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.